Go to: content | top | bottom | search

Abstacts & lectures

Abstract Book

ABSTRACT_BOOK.pdf  (207 Ko)

Main Lectures


Opening lecture

The discovery of Clostridium and its clinical impact. An insight in the history of medicine

Roland Koerner, Sunderland Royal Hospital, Sunderland, UK

Roland_Koerner.pdf  (1821 Ko)

Clostridia in general, their toxins and other pathogenicity factors

Basis of the mode of action of clostridial toxins

Michel-Robert Popoff, Institut Pasteur, Paris, F

MR_Popoff.pdf  (1153 Ko)

Insights into the mechanism of botulinum neurotoxin (BoNT) receptor binding and substrate cleavage from a structural perspective

Axel T. Brunger, Howard Hughes Medical Institute, Stanford, USA

Axel_Brunger.pdf  (2638 Ko)

C. perfringen sepsilon-toxin

Juan Blasi, University of Barcelona, Barcelona, ES

Juan_Blasi.pdf  (17844 Ko)

Comparative genomics of clostridia and pathogenic properties

Holger Brüggemann, Max Planck Institute for Infection Biology, Berlin, DE

C. difficile

Clostridium difficile: an overview of the changes in our understanding the organism over the last 30 years

Maja Rupnik, Instituteof Public Health, Maribor, Slovenia

Maja_Rupnik.pdf  (521 Ko)

C. difficile- the wider perspective (humans, animals, environment)

Viveca Båverud,National Veterinary Institute, Uppsala, SE

Viveca_Baverud.pdf  (4820 Ko)

Clostridium difficile: an overview of the disease, host defences, risk factors and changing host susceptibility

Ian R. Poxton, Centre for Infectious Diseases, Edinburgh, UK

Ian_Poxton.pdf  (887 Ko)

Clinical spectrum of Clostridium difficile Infection (CDI) and the emergence of hypervirulent strains

Ed J. Kuijper, Centre for Infectious Diseases, Leiden, NL

Ed_kuijper.pdf  (2940 Ko)

Clostridia: clinical issues

Clostridial infections in the immunocompromised host

David Dockrell, Royal Hallamshire Hospital, Sheffield, UK

David_Dockrell.pdf  (2472 Ko)

Emerging clostridial infections in USA

L. Clifford McDonald, Centers for Disease Control and Prevention, Atlanta, USA

Clostridia in cancer therapy

Jan Theys,University Maastricht, Maastricht, NL

Jan_Theys.pdf  (1193 Ko)

Toll-like receptors and intestinal inflammation

William F. Stenson,WashingtonUniversity Schoolof Medicine, St-Louis, USA

Afternoon sessions

Regulation of Clostridium difficile toxin expression

Jeroen Corver, Leiden University Medical Center, Leiden, NL

Structure-function analysis of Clostridium difficile toxin E expressed

in Escherichia coli

Alexandra Olling, Hannover Medical School, Hannover, DE

Genotyping of Clostridium difficile in Finland, 2007-2008

Saara Kotila, National Public Health Institute of Finland, Helsinki, FIN

Saara.Kotila.pdf  (241 Ko)

Emergence of Clostridium difficile infection due to a new hypervirulent strain, PCR-ribotype 078

Abraham Goorhuis, Leiden University Medical Center, Leiden, NL

Clinical-epidemiological characterization

of Clostridium difficile-Ribotype 053 - a new strain with high transmissibility

Markus Hell, University Hospital Salzburg, Salzburg, Austria

Markus.Hell.pdf  (383 Ko)

Characterization of Clostridium difficile ribotype 078 from human

and animal origin

Dennis Bakker, Leiden Universty Medical Hospital, Leiden, NL

Denis.Bakker.pdf  (277 Ko)

Isolation of Clostridium difficile from domestic and wild avian species

Mateja Zemljic, Institute of Public Health Maribor, Maribor, Slovenia

Clinical significance of clostridial bacteremia: a retrospective three-year analysis in a French University Hospital Center

Alain Lozniewski, University Hospital Center of Nancy, Nancy, F

Risk factors for Clostridium difficile infections in an endemic setting

in The Netherlands

Abraham Goorhuis, Leiden University Medical Center, Leiden, NL

CH-1015 Lausanne  - Switzerland  -  Tel. +41 21 692 56 00  -  Fax +41 21 692 56 05
Swiss University